Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00809016 | PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy(TEPORL) | completed | N/A | 40 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00874874 | Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery(AngioNext) | completed | Phase 2 | 88 | Centre Oscar LambretOTHER |
| 1 |
| Sep 17, 2026 |
| clinicaltrials |
| NCT00904410 | Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET(CHIMTEP) | completed | Phase 4 | 63 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00905047 | Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer(COLOCROSS) | completed | Phase 3 | 89 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00911092 | Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer(COL) | completed | Phase 4 | 50 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00911911 | Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy(SPAM) | completed | N/A | 66 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00963326 | Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer(CARIO) | completed | — | 30 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT01046487 | Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate(PALANGI3) | completed | Phase 1 | 26 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT01658462 | Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer(VAROCE) | completed | Phase 2 | 51 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT02281149 | Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:(TOMOBREAST) | completed | — | 500 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT02415621 | Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer | completed | Early Phase 1 | 19 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT02704832 | Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)(PREPARE) | completed | N/A | 792 | Institut BergoniéOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT03277638 | Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) | completed | Phase 1 / Phase 2 | 32 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04544748 | A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies | completed | Phase 1 | 48 | AO GENERIUMINDUSTRY | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04556045 | Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer | completed | N/A | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04688151 | Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. | completed | Phase 1 | 22 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04987359 | A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer(Small Steps) | completed | N/A | 33 | Pennington Biomedical Research CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05004441 | Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer | completed | Phase 2 | 43 | Zhou FuxiangOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05021237 | Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer | completed | Phase 2 | 12 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05415527 | Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management(OPTIMOVA) | completed | N/A | 25 | Institut BergoniéOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05798780 | The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | completed | N/A | 40 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT06284304 | A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL(DESTINATION) | completed | N/A | 20 | The Netherlands Cancer InstituteOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT06546839 | SPSIPB vs SAPB for Thoracoscopic Surgery | completed | N/A | 46 | Medipol UniversityOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07799909 | Behavioral Activation for Cancer-Related Fatigue After Breast Cancer Surgery | completed | N/A | 114 | Huaidong ChengOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07819045 | Self-Acceptance and Supportive Accountability for Active Living Among Adults Receiving Chemotherapy | completed | N/A | 42 | University of OklahomaOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07824505 | Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy | completed | Phase 2 | 74 | Haihe Biopharma Co., Ltd.INDUSTRY | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07824778 | Construction and Application Research of a Multidisciplinary Combined Exercise Management Program for Elderly Lung Cancer Patients After Surgery Based on Social Cognitive Theory | completed | N/A | 68 | Sir Run Run Shaw HospitalOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00341276 | Esophageal Cancer Genetics Studies | completed | — | 7,705 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT00342888 | Case-Control Study of Pesticides and Childhood Leukemia | completed | — | 629 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT00450788 | Esophageal Cancer in Northeastern Iran | completed | — | 50,045 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT01352962 | Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT01445483 | Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases | completed | — | 35 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03389347 | High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | completed | N/A | 40 | University of WashingtonOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03418480 | HARE-40: HPV Anti-CD40 RNA vaccinE(HARE-40) | completed | Phase 1 / Phase 2 | 32 | University of SouthamptonOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03460080 | Diagnostic Value of AFP-L3 and PIVKA-II in HCC | completed | — | 200 | Hanoi Medical UniversityOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03543189 | Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03667612 | Endogenous Mechanisms of Inactivation of the Endothelium Tumor(BreastIls) | completed | — | 70 | Centre Oscar LambretOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT04533555 | Genetic Testing in Young Adults With Cancer Study(Gen-Y) | completed | N/A | 749 | University of PennsylvaniaOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05001009 | Goals of Care Conversations Study(LSTDI) | completed | N/A | 2,859 | VA Office of Research and DevelopmentFED | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05249426 | A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer | completed | Phase 1 | 48 | Boehringer IngelheimINDUSTRY | 11 | Sep 16, 2026 | clinicaltrials |
| NCT05775705 | L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH | completed | N/A | 24 | Beijing Friendship HospitalOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05898009 | Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2(CanSeR-OGen) | completed | N/A | 228 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT07785791 | ERAS Compliance and Nutritional Outcomes After Lung Cancer Surgery(ERAS-NUTRI) | completed | — | 120 | Bursa City HospitalOTHER_GOV | 1 | Sep 16, 2026 | clinicaltrials |
| NCT02598219 | Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.(SENTIRAD) | completed | Phase 3 | 262 | Centre Oscar LambretOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04004455 | Pain, Body Composition and Physical Activity in Childhood Cancer. | completed | — | 60 | Vrije Universiteit BrusselOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05206331 | CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study | completed | Phase 4 | 2,089 | Margarita Louise ZuleyOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05670106 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC | completed | Phase 2 | 62 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06236425 | TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | completed | Phase 1 | 7 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06435871 | Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors | completed | N/A | 55 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07259616 | Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities | completed | — | 46,079 | Gynaecologisch Oncologisch Centrum ZuidOTHER | 0 | Sep 15, 2026 | clinicaltrials |
Data updated 14 days agoSource updated Sep 17, 2026source: clinicaltrials